Joshua Remland - Dana-Farber Cancer Institute, Harvard Medical School

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 57 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

The Prognostic Value of HER2 Gene Dosage and Heterogeneity at a Single-Cell Resolution in Gastroesophageal Adenocarcinoma

Yashika Parashar, Leigh Culnane,Joshua Remland,Chetan Nambiar, Chen Yuan, Shagun Nasta,Adam Bard,Haeseong Park,Samuel J. Klempner,Marios Giannakis,Andrew Aguirre,Kimmie Ng,Jeffrey A. Meyerhardt, Brian M. Wolpin,Rona Yaeger,James M. Cleary, Charlotte Wang,Peter C. Enzinger,Nilay S. Sethi,Harshabad Singh

Journal of Clinical Oncologyno. 4_suppl (2025): 473-473

Cited0Views0Bibtex

Cell States and Neighborhoods in Distinct Clinical Stages of Primary and Metastatic Esophageal Adenocarcinoma

Josephine Yates, Camille Mathey-Andrews,Jihye Park,Amanda Garza, Andréanne Gagné,Samantha Hoffman,Kevin Bi,Breanna Titchen,Connor Hennessey,Joshua Remland, Matthew Carnes,Erin Shannon,Sabrina Camp, Siddhi Balamurali, Shweta Kiran Cavale,Zhixin Li,Akhouri Kishore Raghawan,Agnieszka Kraft,Genevieve Boland,Andrew J Aguirre,Nilay S Sethi,Valentina Boeva,Eliezer M Van Allen

Cell reports Medicineno. 6 (2025): 102188-102188

Cited0Views0WOSBibtex

Supplementary Figure 3 from ras/raf Comutation and erbb2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer

openalex

Cited0Views0Bibtex

Supplementary Figure 4 from RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer

crossref（2024）

Cited0Views0Bibtex

Supplementary Table 9 from RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer

crossref（2024）

Cited0Views0Bibtex

Supplementary Table 2 from RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer

crossref（2024）

Cited0Views0Bibtex

Supplementary Methods 1 from RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer

crossref（2024）

Cited0Views0Bibtex

Supplementary Figure 3 from RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer

crossref（2024）

Cited0Views0Bibtex

Supplementary Figure 2 from ras/raf Comutation and erbb2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer

openalex（2024）

Cited0Views0Bibtex

Supplementary Table 4 from RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer

crossref（2024）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn